In this episode, Joe interviews the Co-Founders of Tesselate Therapeutics: Dr. Rochelle Hines, Ph.D. (also the CEO and an Associate Professor at UNLV), and Dr. Dustin Hines, Ph.D. (the CSO as well as an Assistant Professor at UNLV).Research chemicalsWhile Tesselate’s primary objective is the development of novel psychedelic molecules, the Hines�
PT366 – Neurotransmitter Systems and Novel Psychedelic Molecules
In this episode, Joe interviews the Co-Founders of Tesselate Therapeutics: Dr. Rochelle Hines, Ph.D. (also the CEO and an Associate Professor at UNLV), and Dr. Dustin Hines, Ph.D. (the CSO as well as an Assistant Professor at UNLV).Research chemicalsWhile Tesselate’s primary objective is the development of novel psychedelic molecules, the Hines�